Traders purchased shares of AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) on weakness during trading on Thursday. $70.02 million flowed into the stock on the tick-up and $42.36 million flowed out of the stock on the tick-down, for a money net flow of $27.66 million into the stock. Of all equities tracked, AmerisourceBergen Corporation (Holding Co) had the 26th highest net in-flow for the day. AmerisourceBergen Corporation (Holding Co) traded down ($3.63) for the day and closed at $80.69

A number of research analysts recently commented on the company. Zacks Investment Research raised AmerisourceBergen Corporation (Holding Co) from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. Bank of America Corporation cut AmerisourceBergen Corporation (Holding Co) from a “buy” rating to a “neutral” rating and reduced their target price for the company from $95.76 to $94.00 in a research note on Friday, June 30th. Leerink Swann set a $90.00 target price on AmerisourceBergen Corporation (Holding Co) and gave the company a “buy” rating in a research note on Monday, August 7th. Jefferies Group LLC reissued a “hold” rating and issued a $95.00 target price on shares of AmerisourceBergen Corporation (Holding Co) in a research note on Wednesday, June 21st. Finally, BidaskClub cut AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. AmerisourceBergen Corporation (Holding Co) presently has an average rating of “Hold” and a consensus target price of $92.34.

The stock’s 50 day moving average is $81.75 and its 200-day moving average is $87.67. The firm has a market capitalization of $17.88 billion, a price-to-earnings ratio of 21.26 and a beta of 0.95.

AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last posted its earnings results on Thursday, August 3rd. The company reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.06. AmerisourceBergen Corporation (Holding Co) had a net margin of 0.56% and a return on equity of 56.07%. The firm had revenue of $38.71 billion for the quarter, compared to the consensus estimate of $39.13 billion. During the same period in the previous year, the firm posted $1.37 EPS. The business’s quarterly revenue was up 4.9% on a year-over-year basis. Equities research analysts anticipate that AmerisourceBergen Corporation will post $5.88 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 5th. Stockholders of record on Monday, August 21st were issued a $0.365 dividend. The ex-dividend date was Thursday, August 17th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 1.79%. AmerisourceBergen Corporation (Holding Co)’s dividend payout ratio (DPR) is presently 38.02%.

In other news, Chairman Steven H. Collis sold 15,000 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $79.92, for a total value of $1,198,800.00. Following the sale, the chairman now directly owns 253,876 shares in the company, valued at approximately $20,289,769.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Peyton R. Howell sold 20,000 shares of the business’s stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $80.00, for a total transaction of $1,600,000.00. Following the completion of the sale, the insider now owns 57,135 shares in the company, valued at $4,570,800. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 51,273 shares of company stock worth $4,323,237. Insiders own 27.40% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Burgundy Asset Management Ltd. increased its holdings in shares of AmerisourceBergen Corporation (Holding Co) by 3.3% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 2,649,123 shares of the company’s stock worth $250,422,000 after buying an additional 84,163 shares during the last quarter. Intl Fcstone Inc. bought a new stake in shares of AmerisourceBergen Corporation (Holding Co) in the 2nd quarter worth about $201,000. Achmea Investment Management B.V. increased its holdings in shares of AmerisourceBergen Corporation (Holding Co) by 7.8% in the 2nd quarter. Achmea Investment Management B.V. now owns 29,338 shares of the company’s stock worth $2,770,000 after buying an additional 2,123 shares during the last quarter. Lord Abbett & CO. LLC increased its holdings in shares of AmerisourceBergen Corporation (Holding Co) by 14.5% in the 2nd quarter. Lord Abbett & CO. LLC now owns 175,000 shares of the company’s stock worth $16,543,000 after buying an additional 22,200 shares during the last quarter. Finally, Toronto Dominion Bank increased its holdings in shares of AmerisourceBergen Corporation (Holding Co) by 16.9% in the 2nd quarter. Toronto Dominion Bank now owns 82,452 shares of the company’s stock worth $7,797,000 after buying an additional 11,948 shares during the last quarter. Hedge funds and other institutional investors own 67.67% of the company’s stock.

WARNING: “Traders Buy Shares of AmerisourceBergen Corporation (Holding Co) (ABC) on Weakness” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/16/traders-buy-shares-of-amerisourcebergen-corporation-holding-co-abc-on-weakness.html.

About AmerisourceBergen Corporation (Holding Co)

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Receive News & Stock Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related stocks with our FREE daily email newsletter.